HIGHLIGHTS
- who: Yi-Fong Chen and collaborators from the Graduate Institute of Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Medical University, Taiwan have published the Article: In Vitro and In Silico Biological Studies of 4-Phenyl-2-Quinolone (4-PQ) Derivatives as Anticancer Agents, in the Journal: Molecules 2023, 555 of 21/Dec/2022
- what: In this study, molecular docking was simulated to investigate the binding modalities of 4-PQ derivatives against tubulin using AutoDock4 and AutoDock Vina software . The authors identified 4-PQ compounds with extensive interactions with amino_acids of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.